Biomarker for Duchenne Muscular Dystrophy

Clinical trial NCT02994030 · COMPLETED

Trial details

NCT number: NCT02994030
Sponsor: CENTOGENE GmbH Rostock
Status: COMPLETED
Study type: OBSERVATIONAL

Increased Lordosis/Scoliosis Hyporeflexia Duchenne Muscular Dystrophy Red-Green Color Blindness Lordosis Scoliosis Muscular Atrophy Muscular Weakness

Start date: 2018-08-20
Primary completion: 2022-03-11
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.